Literature DB >> 27023021

Understanding vaccination rates and attitudes among patients with rheumatoid arthritis.

Diana S Sandler, Eric M Ruderman1, Tiffany Brown, Ji Young Lee, Amanda Mixon, David T Liss, David W Baker.   

Abstract

OBJECTIVES: Appropriate vaccinations are important for patients with rheumatoid arthritis (RA), who are often treated with highly immunosuppressive therapies that increase their risk of infection. However, rates of vaccination among patients with RA are below optimal levels. STUDY
DESIGN: We conducted a patient survey to assess self-reported vaccination status and to compare that status with electronic health record (EHR) data.
METHODS: We recruited randomly selected patients with RA in an academic practice in 2013. Eligible participants had a diagnosis of RA, at least 1 visit to a rheumatology clinic in each of the previous 2 years, were 18 years or older, and had English listed as their preferred language. The survey included the following domains: a) patient self-reported receipt of influenza, pneumococcal (PNVX), and herpes zoster (HZVX) vaccinations; b) attitudes about these vaccines, including reasons for unvaccinated status, if applicable; and c) provider recommendations about these vaccines.
RESULTS: Based on participants' self-report, we found a high vaccination rate for influenza during the previous season (79.4%), a moderate rate of any previous vaccination for pneumococcus (53.9%), and a very low rate of any previous vaccination for herpes zoster (7.8%). If we assume that all self-reports are accurate and we include vaccinations recorded in the EHR that were not reported by patients, the vaccination rates were approximately 8% to 9% higher for PNVX and HZVX.
CONCLUSIONS: Vaccination rates are low among patients with RA based on self-report data. Further research is needed to investigate system-level barriers to vaccination and the impact of evidence-based, provider-level interventions on vaccination rates.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023021

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  6 in total

1.  A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.

Authors:  David W Baker; Tiffany Brown; Ji Young Lee; Amanda Ozanich; David T Liss; Diana S Sandler; Eric M Ruderman
Journal:  J Rheumatol       Date:  2016-04-15       Impact factor: 4.666

Review 2.  Understanding factors associated with vaccine uptake and vaccine hesitancy in patients with rheumatoid arthritis: a scoping literature review.

Authors:  Vincent Gosselin Boucher; Sandra Pelaez; Claudia Gemme; Sara Labbe; Kim L Lavoie
Journal:  Clin Rheumatol       Date:  2020-07-03       Impact factor: 2.980

3.  The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States.

Authors:  Robin K Dore; Jenya N Antonova; Chakkarin Burudpakdee; Lawrence Chang; Magdaliz Gorritz; Mark C Genovese
Journal:  ACR Open Rheumatol       Date:  2021-11-18

4.  Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort.

Authors:  Viviane Ta; Orit Schieir; Marie-France Valois; Ines Colmegna; Carol Hitchon; Louis Bessette; Glen Hazlewood; Carter Thorne; Janet Pope; Gilles Boire; Diane Tin; Edward C Keystone; Vivian P Bykerk; Susan J Bartlett
Journal:  ACR Open Rheumatol       Date:  2022-03-29

5.  Clinician's Perceptions of a CME Activity to Increase Knowledge of Vaccination in Adults with Chronic Inflammatory Conditions.

Authors:  Saira Z Sheikh; Edward G A Iglesia; Matthew Underwood; Shruti Saxena-Beem; Mildred Kwan
Journal:  Lupus (Los Angel)       Date:  2019-11-29

6.  Vaccination status of patients using anti-TNF therapy and the physicians' behavior shaping the phenomenon: Mixed-methods approach.

Authors:  Hussain Abdulrahman Al-Omar; Hadeel Magdy Sherif; Ahmed Yaccob Mayet
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.